The Opioid Epidemic: What can we do differently?

A Webinar Series offered by the Central East Addiction Technology Transfer Center, in collaboration with the Regional Office (Region III) of the U.S. Department of Health and Human Services and the Mid-Atlantic Training Collaborative for Health and Human Services (MATCHHS).
 
THE PROBLEM: Drug overdose deaths and opioid-involved deaths continue to increase in the United States (U.S.).  91 Americans die every day from an opioid overdose.  From 2000 to 2015, more than half a million people died from drug overdoses, the majority of them (more than six out of ten) involving an opioid.   Since 1999, the number of overdose deaths involving opioids (including heroin and prescription drugs such as oxycodone, hydrocodone, and methadone) quadrupled.  This series is designed to assist health and human service providers working in a variety of settings with developing strategies to address the opioid public health crisis in the U.S.  (Source: CDC)
 
February 28, 2017
 
PARTICIPANTS: This webinar series is designed for healthcare and human service providers including physicians, physician assistants, nurse practitioners, nurse midwives, nurses, counselors, social workers, case managers, and other staff who interact with patients, who work in multiple types of settings including primary care, geriatric care, maternal and child health care, Head Start programs, STD/HIV & reproductive health care, mental health, addictions, health departments, hospitals, health centers, schools, and community health settings.
 
CONTINUING EDUCATION**
Applications for continuing education credits have been submitted (by the Institute for Research, Education, and Training on Addiction) as follows:
  • ACCME - Accreditation Council for Continuing Medical Education
  • NAADAC - The Association for Addiction Professionals
  • Health Education – The National Commission for Health Education Credentialing
  • Social Work - Issued by the University of Pittsburgh School of Social Work
                      o   Note: If the application is approved, social work credits will be issued only for a minimum of two hours of participation, plus one-hour increments thereafter.
* Continuing Medical Education for the Opioid Prescribing: Safe Practice, Changing Lives course is provided by the American Society for Addiction Medicine.  See event flyer for related information.
** Continuing education will be provided only for synchronous participation on-line or in-person during the event.  Continuing education will not be offered for audio-only participation (i.e., calling-in), nor for viewing or listening to recorded sessions.
 

Medications Used to Treat Opioid Addiction

Date: Tuesday, February 7, 2017                    Time: 3:00pm - 4:00pm (EST)
 
Get the transcript HERE!
DESCRIPTION:
If you are a health and human service professional, you have probably at least heard of medication-assisted treatment (MAT) for opioid addiction, but do you really understand it?  Do you know what it is, by whom it can be administered, for whom it is appropriate, how it works, what kinds of medication are involved, and whether or not there are opportunities for you or your organization to help promote this evidence-based medical practice?  If you want to know the answers to those questions, attend this webinar.
OBJECTIVES:
After participating in this webinar, you will be able to:
  • Define MAT for opioid addiction
  • Describe risks and benefits of MAT
  • Recognize medications used in MAT
  • Identify MAT resources for consumers
PARTICIPANTS:
This webinar is designed for health care providers including physicians, physician assistants, nurse practitioners, nurse midwives, nurses, counselors, social workers, case managers, and other staff who interact with patients, who work in multiple types of settings including primary care, geriatric care, maternal and child health care, STD/HIV & reproductive health care, mental health, addictions, health departments, hospitals, health centers, schools, and community health settings.
FACULTY:
Marc Fishman, MD
Dr. Fishman is an addiction psychiatrist and a member of the faculty of the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. He is the Medical Director of Maryland Treatment Centers, a regional behavioral healthcare provider, which offers programs for residential and outpatient treatment of drug-involved and dual-diagnosis adolescents and adults. Dr. Fishman is a national expert on adolescent addiction treatment and program development. His academic work has focused on models of care and treatment outcomes for addictions in youth, in particular opioid dependence.
 

Working Together to Address Opioid Addiction:

We are all part of the solution!

Date: Tuesday, February 21, 2017                  Time: 12:30pm - 1:30pm (EST)
 
Get the transcript HERE!
DESCRIPTION:
Prescription drug abuse is a growing epidemic in the United States and demands our attention.  It affects our lives, our communities, and our country, and our world.  It affects all of us socially, emotionally, financially, professionally, physically, cognitively, and environmentally.  Whether you work in a school, hospital, police department, health center, community center, shelter, or any other health or human service setting, there is a role that you or your organization can play to positively impact the opioid use epidemic. This webinar will explore such roles for your consideration.
OBJECTIVES:
After participating in this webinar, you will be able to:
  • Describe individual and organizational tactics to promote opioid use screening and abuse prevention.
  • Identify models of community partnerships that can be effective in reducing opioid abuse.
PARTICIPANTS:
This webinar is designed for health care providers including physicians, physician assistants, nurse practitioners, nurse midwives, nurses, counselors, social workers, case managers, and other staff who interact with patients, who work in multiple types of settings including primary care, geriatric care, maternal and child health care, STD/HIV & reproductive health care, mental health, addictions, health departments, hospitals, health centers, schools, and community health settings.
FACULTY:
Renata J. Henry, M.Ed.
Ms. Henry has over 35 years of experience in behavioral health, serving in leadership positions in mental health, substance abuse, and state and county government. Currently she is Executive Director of the Danya Institute which operates the Central East Addictions Technology Transfer Center.  Prior to joining Danya Institute in 2013, positions held include the Deputy Secretary for Behavioral Health and Disabilities with the Maryland Department of Health and Mental Hygiene, and Director of the Division of Substance Abuse and Mental Health of Delaware Health and Social Services. Ms. Henry has provided national leadership in various capacities, including as a member of the Advisory Mental Health Council for the National Institutes of Health and SAMHSA’s Advisory Committee for Women’s Services, and as President of the Board of Directors of the National Association of State Mental Health Program Directors. Renata is the mother of two daughters and says they are her greatest achievement.
 

Opioid Prescribing: Safe Practice, Changing Lives

Date: Tuesday, February 28, 2017              Time: 12:00pm - 3:00pm (EST)
 
Get the transcript HERE!
DESCRIPTION:
We now know that overdoses from prescription opioids are a driving factor in the 15-year increase in opioid overdose deaths.  Since 1999, the amount of prescription opioids sold in the U.S.  has nearly quadrupled, yet there has not been an overall change in the amount of pain that Americans report.  This comprehensive course, developed by experts from Collaborative for REMS Education (CO*RE), incorporates all six units outlined in the FDA blueprint for safe opioid prescribing.  Attend this webinar if you want to be able to:
  • Counsel patients and caregivers about safer use of opioids;
  • Describe strategies for diagnosing and managing opioid-addicted patients; and
  • Practice techniques for safe opioid prescribing.
PARTICIPANTS:
This webinar is designed for healthcare and human service providers including physicians, physician assistants, nurse practitioners, nurse midwives, nurses, counselors, social workers, case managers, and other staff who interact with patients, who work in multiple types of settings including primary care, geriatric care, maternal and child health care, Head Start programs, STD/HIV & reproductive health care, mental health, addictions, health departments, hospitals, health centers, schools, and community health settings.  Prescribers of extended-release and long-acting opioids are particularly welcome, including pain specialists, primary care physicians, physician assistants, nurse practitioners, advanced practice nurses, dentists, addiction medicine physicians, psychiatrists and other physicians and clinicians who prescribe opioids.
FACULTY:
Yngvild K. Olsen, MD, MPH, FASAM
Dr. Olsen is a graduate of Harvard Medical School, did her residency training in internal medicine at the Boston University’s Boston Medical Center, and received a Master’s in Public Health from the Johns Hopkins University Bloomberg School of Public Health. She is Board-certified in Addiction Medicine through ABAM. She currently serves as the Medical Director for the Institutes for Behavior Resources Inc./REACH (Recovery Enhanced by Access to Comprehensive Healthcare and as a consultant on integrated care initiatives in Baltimore City.  She previously served as the Vice President of Clinical Affairs and Medical Director for the Baltimore Substance Abuse System, Inc. (BSAS). Dr. Olsen has written and lectured extensively on addiction, opioid dependence, and co-morbid medical issues, including chronic pain.
 
 
Opioid Prescribing: Safe Practice, Changing Lives (continued)
 
ASAM’s CO*RE REMS CME Information
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This course has been designated as an approved CME Activity by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 3 AMA PRA Category 1 Credit(s)™ to the CME requirement for Part II: Lifelong Learning and Self-Assessment.
 
RPC Commercial Support Disclosure Statement
This educational activity is supported by an independent educational grant from the extended-release and long-acting (ER/LA) Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com  or a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).
 
Acknowledgement
Presented by the American Society of Addiction Medicine, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.
 
CME is provided based on the following learning objectives:
  • Describe appropriate patient assessment for treatment with extended-release and long-acting (ER/LA) opioid analgesics, evaluating risks and potential benefits of ER/LA therapy, as well as possible misuse.
  • Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques, as well as appropriate discontinuation strategies.
  • Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects.
  • Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
  • Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids.